# Trial of XELIRI/FOLFIRI + Simvastatin Followed by Simvastatin Maintenance in Metastatic Colorectal Cancer

> **NCT01238094** · PHASE3 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 258 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT01238094
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-04
- **Primary completion:** 2013-11
- **Final completion:** 2014-05
- **Target enrollment:** 258 (ESTIMATED)
- **Last updated:** 2013-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01238094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01238094, "Trial of XELIRI/FOLFIRI + Simvastatin Followed by Simvastatin Maintenance in Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01238094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*